Back to Search
Start Over
EE438 Cost-Effectiveness of Nirsevimab Against Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV LRTD) in the US Birth Cohort.
- Source :
-
Value in Health . 2023 Supplement, Vol. 26 Issue 12, pS135-S135. 1p. - Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 10983015
- Volume :
- 26
- Issue :
- 12
- Database :
- Academic Search Index
- Journal :
- Value in Health
- Publication Type :
- Academic Journal
- Accession number :
- 174417484
- Full Text :
- https://doi.org/10.1016/j.jval.2023.09.704